Spatial and graded heterogeneity of GD2 expression in neuroblastoma revealed by whole-slide immunohistochemistry
Cancer Immunology, Immunotherapy · 2026
DOI: 10.1007/s00262-026-04508-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Tomoko Fujikawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Neuroblastoma, Gangliosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japanese Society of Pediatric Hematology/Oncology, Oomasari Research Grant.
Abstract (Originalsprache)
BACKGROUND: Anti-GD2 immunotherapy has improved outcomes in high-risk neuroblastoma; however, therapeutic responses remain heterogeneous. Although GD2 is generally assumed to be uniformly expressed in neuroblastoma, its spatial distribution within clinical tumors has not been systematically characterized. We therefore investigated intratumoral GD2 heterogeneity using whole-slide immunohistochemistry and explored its molecular regulation. METHODS: GD2 expression was evaluated in 45 FFPE neuroblastoma tumors using standardized whole-slide immunohistochemistry and independently assessed by two pathologists. GD2 surface expression was analyzed by flow cytometry in 12 neuroblastoma cell lines. Functional roles of ganglioside biosynthetic enzymes were evaluated using siRNA-mediated knockdown. RESULTS: Whole-slide immunohistochemistry demonstrated frequent intratumoral GD2 heterogeneity. Fourteen tumors (31%) contained
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Pathology, Kobe Children's Hospital, Kobe, Japan.
- Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan.
- Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan. atamura@med.kobe-u.ac.jp.
ORCID-Profile: Akihiro Tamura
Förderung
- Japan Society for the Promotion of Science
- Japanese Society of Pediatric Hematology/Oncology
- Oomasari Research Grant
- Hyogo Health Foundation
- Gold Ribbon Network
- Takeda Science Foundation
- Kawano Masanori Memorial Foundation for Pediatric Research
- Kobe University CMX Research Program
Zitieren
APA
Fujikawa, T., Inoue, S., Nishimura, A., Nakatani, N., Yamamoto, N., Hyodo, T., Yoshida, M., Hasegawa, D., Nozu, K., & Tamura, A. (2026). Spatial and graded heterogeneity of GD2 expression in neuroblastoma revealed by whole-slide immunohistochemistry. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04508-7
Vancouver
Fujikawa T, Inoue S, Nishimura A, Nakatani N, Yamamoto N, Hyodo T, et al. Spatial and graded heterogeneity of GD2 expression in neuroblastoma revealed by whole-slide immunohistochemistry. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04508-7
BibTeX
@article{Fujikawa2026,
author = {Fujikawa, Tomoko and Inoue, Shotaro and Nishimura, Akihiro and Nakatani, Naoko and Yamamoto, Nobuyuki and Hyodo, Toshiki and Yoshida, Makiko and Hasegawa, Daiichiro and Nozu, Kandai and Tamura, Akihiro},
title = {Spatial and graded heterogeneity of GD2 expression in neuroblastoma revealed by whole-slide immunohistochemistry},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04508-7}
}
EUVIMED